| Name | 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- |
|---|---|
| Synonyms | Neuromuscular Disorder-Targeting Compound 1 |
| Description | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. |
|---|---|
| Related Catalog | |
| In Vitro | Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome[1]. |
| References |
| No Any Chemical & Physical Properties |